當(dāng)前位置：首頁(yè) JCRQ3 期刊介紹(非官網(wǎng))

International Journal Of Laboratory HematologySCIE

國(guó)際簡(jiǎn)稱：INT J LAB HEMATOL 參考譯名：國(guó)際實(shí)驗(yàn)室血液學(xué)雜志

中科院分區(qū)
4區(qū)
CiteScore分區(qū)
Q2
JCR分區(qū)
Q3

基本信息：: ISSN：1751-5521; 是否OA：未開放; 是否預(yù)警：否; TOP期刊：否

出版信息：: 出版地區(qū)：ENGLAND; 出版商：Wiley-Blackwell Publishing Ltd; 出版語(yǔ)言：English; 出版周期：Bimonthly; 出版年份：2007; 研究方向：醫(yī)學(xué)-血液學(xué)

評(píng)價(jià)信息：: 影響因子：2.2; H-index：46; CiteScore指數(shù)：4.5; SJR指數(shù)：0.555; SNIP指數(shù)：0.715

發(fā)文數(shù)據(jù)：: Gold OA文章占比：13.06%; 研究類文章占比：80.17%; 年發(fā)文量：121; 自引率：0.0666...; 開源占比：0.079; 出版撤稿占比：0; 出版國(guó)人文章占比：0.08; OA被引用占比：0.0511...

投稿咨詢加急見(jiàn)刊

英文簡(jiǎn)介期刊介紹 CiteScore數(shù)據(jù) 中科院SCI分區(qū) JCR分區(qū) 發(fā)文數(shù)據(jù) 常見(jiàn)問(wèn)題

英文簡(jiǎn)介International Journal Of Laboratory Hematology期刊介紹

The International Journal of Laboratory Hematology provides a forum for the communication of new developments, research topics and the practice of laboratory haematology.

The journal publishes invited reviews, full length original articles, and correspondence.

The International Journal of Laboratory Hematology is the official journal of the International Society for Laboratory Hematology, which addresses the following sub-disciplines: cellular analysis, flow cytometry, haemostasis and thrombosis, molecular diagnostics, haematology informatics, haemoglobinopathies, point of care testing, standards and guidelines.

The journal was launched in 2006 as the successor to Clinical and Laboratory Hematology, which was first published in 1979. An active and positive editorial policy ensures that work of a high scientific standard is reported, in order to bridge the gap between practical and academic aspects of laboratory haematology.

期刊簡(jiǎn)介International Journal Of Laboratory Hematology期刊介紹

《International Journal Of Laboratory Hematology》自2007出版以來(lái)，是一本醫(yī)學(xué)優(yōu)秀雜志。致力于發(fā)表原創(chuàng)科學(xué)研究結(jié)果，并為醫(yī)學(xué)各個(gè)領(lǐng)域的原創(chuàng)研究提供一個(gè)展示平臺(tái)，以促進(jìn)醫(yī)學(xué)領(lǐng)域的的進(jìn)步。該刊鼓勵(lì)先進(jìn)的、清晰的闡述，從廣泛的視角提供當(dāng)前感興趣的研究主題的新見(jiàn)解，或?qū)彶槎嗄陙?lái)某個(gè)重要領(lǐng)域的所有重要發(fā)展。該期刊特色在于及時(shí)報(bào)道醫(yī)學(xué)領(lǐng)域的最新進(jìn)展和新發(fā)現(xiàn)新突破等。該刊近一年未被列入預(yù)警期刊名單，目前已被權(quán)威數(shù)據(jù)庫(kù)SCIE收錄，得到了廣泛的認(rèn)可。

該期刊投稿重要關(guān)注點(diǎn)：

預(yù)計(jì)審稿時(shí)間：較慢,6-12周
醫(yī)學(xué)
HEMATOLOGY
SCIE
中科院4區(qū)
非預(yù)警

Cite Score數(shù)據(jù)（2024年最新版）International Journal Of Laboratory Hematology Cite Score數(shù)據(jù)

CiteScore：4.5
SJR：0.555
SNIP：0.715

學(xué)科類別	分區(qū)	排名	百分位
大類：Medicine 小類：Biochemistry (medical)	Q2	29 / 72	60%
大類：Medicine 小類：Hematology	Q2	56 / 137	59%
大類：Medicine 小類：Clinical Biochemistry	Q3	62 / 117	47%

CiteScore 是由Elsevier(愛(ài)思唯爾)推出的另一種評(píng)價(jià)期刊影響力的文獻(xiàn)計(jì)量指標(biāo)。反映出一家期刊近期發(fā)表論文的年篇均引用次數(shù)。CiteScore以Scopus數(shù)據(jù)庫(kù)中收集的引文為基礎(chǔ)，針對(duì)的是前四年發(fā)表的論文的引文。CiteScore的意義在于，它可以為學(xué)術(shù)界提供一種新的、更全面、更客觀地評(píng)價(jià)期刊影響力的方法，而不僅僅是通過(guò)影響因子(IF)這一單一指標(biāo)來(lái)評(píng)價(jià)。

歷年Cite Score趨勢(shì)圖

中科院SCI分區(qū)International Journal Of Laboratory Hematology 中科院分區(qū)

中科院 2023年12月升級(jí)版 綜述期刊：否 Top期刊：否

大類學(xué)科	分區(qū)	小類學(xué)科	分區(qū)
醫(yī)學(xué)	4區(qū)	HEMATOLOGY 血液學(xué)	4區(qū)

中科院分區(qū)表 是以客觀數(shù)據(jù)為基礎(chǔ)，運(yùn)用科學(xué)計(jì)量學(xué)方法對(duì)國(guó)際、國(guó)內(nèi)學(xué)術(shù)期刊依據(jù)影響力進(jìn)行等級(jí)劃分的期刊評(píng)價(jià)標(biāo)準(zhǔn)。它為我國(guó)科研、教育機(jī)構(gòu)的管理人員、科研工作者提供了一份評(píng)價(jià)國(guó)際學(xué)術(shù)期刊影響力的參考數(shù)據(jù)，得到了全國(guó)各地高校、科研機(jī)構(gòu)的廣泛認(rèn)可。

中科院分區(qū)表 將所有期刊按照一定指標(biāo)劃分為1區(qū)、2區(qū)、3區(qū)、4區(qū)四個(gè)層次，類似于“優(yōu)、良、及格”等。最開始，這個(gè)分區(qū)只是為了方便圖書管理及圖書情報(bào)領(lǐng)域的研究和期刊評(píng)估。之后中科院分區(qū)逐步發(fā)展成為了一種評(píng)價(jià)學(xué)術(shù)期刊質(zhì)量的重要工具。

歷年中科院分區(qū)趨勢(shì)圖

JCR分區(qū)International Journal Of Laboratory Hematology JCR分區(qū)

2023-2024 年最新版

按JIF指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：HEMATOLOGY	SCIE	Q3	53 / 97	45.9%

按JCI指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：HEMATOLOGY	SCIE	Q3	59 / 97	39.69%

JCR分區(qū)的優(yōu)勢(shì)在于它可以幫助讀者對(duì)學(xué)術(shù)文獻(xiàn)質(zhì)量進(jìn)行評(píng)估。不同學(xué)科的文章引用量可能存在較大的差異，此時(shí)單獨(dú)依靠影響因子(IF)評(píng)價(jià)期刊的質(zhì)量可能是存在一定問(wèn)題的。因此，JCR將期刊按照學(xué)科門類和影響因子分為不同的分區(qū)，這樣讀者可以根據(jù)自己的研究領(lǐng)域和需求選擇合適的期刊。

歷年影響因子趨勢(shì)圖

發(fā)文數(shù)據(jù)

2023-2024 年國(guó)家/地區(qū)發(fā)文量統(tǒng)計(jì)

國(guó)家/地區(qū)數(shù)量
USA172
CHINA MAINLAND123
Spain91
Belgium79
India75
South Korea68
England67
Japan65
Canada64
France64

本刊中國(guó)學(xué)者近年發(fā)表論文

1、A stepwise haematological screening and whole-exome sequencing reveal multiple mutations from SUPT5H causing an elevation of Hb A(2) from a cohort of 47336 individuals
Author: Lou, Jiwu; Ye, Yuhua; Sun, Manna; Zhao, Ying; Fu, Youqing; Liu, Yanhui

Journal: INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY. 2023; Vol. 45, Issue 1, pp. 90-95. DOI: 10.1111/ijlh.13959
2、Reference intervals for erythrocyte parameters and hemoglobin electrophoresis parameters for young children in Guangxi
Author: Zhou, Chaofan; He, Sheng; Liu, Dun; Zuo, Yangjin; Chen, Qiuli; Wang, Liang; Chen, Biyan; Chen, Faqin; Luo, Jingsi; Xu, Xiangmin; Lin, Li

Journal: INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY. 2023; Vol. 45, Issue 1, pp. 104-111. DOI: 10.1111/ijlh.13965
3、High CX3CR1 expression predicts poor prognosis in paediatric acute myeloid leukaemia undergoing hyperleukocytosis
Author: Mei, Nan; Su, Hong; Gong, Sha; Du, Hanzhi; Zhang, Xiaojuan; Wang, Lu; Wang, Huaiyu

Journal: INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY. 2023; Vol. 45, Issue 1, pp. 53-63. DOI: 10.1111/ijlh.13963
4、Anaemia can be improved by controlling the disease activity of Takayasu's arteritis without iron administration
Author: Guo, Yanqiu; Du, Juan; Li, Taotao; Gao, Na; Pan, Lili

Journal: INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY. 2023; Vol. 45, Issue 1, pp. 112-118. DOI: 10.1111/ijlh.13972
5、Effects of CD34(+) cell dose on haematopoietic recovery in acute lymphoblastic leukaemia patients with positive pretransplant measurable residual disease
Author: Wang, Yuewen; Mo, Xiaodong; Cheng, Yifei; Chen, Yuhong; Lv, Meng; Wang, Fengrong; Yan, Chenhua; Han, Wei; Chen, Huan; Xu, Lanping; Wang, Yu; Zhang, Xiaohui; Liu, Kaiyan; Huang, Xiaojun; Chang, Yingjun

Journal: INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY. 2023; Vol. 45, Issue 1, pp. 72-81. DOI: 10.1111/ijlh.13974
6、Adult mixed phenotype acute leukemia (MPAL): B/myeloid MPAL(isoMPO) is distinct from other MPAL subtypes
Author: Weinberg, Olga K.; Dennis, Jake; Zia, Hamid; Chen, Pu; Chu, Andrew; Koduru, Prasad; Luu, Hung S.; Fuda, Franklin; Chen, Weina

Journal: INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY. 2023; Vol. 45, Issue 2, pp. 170-178. DOI: 10.1111/ijlh.13988
7、The adverse impact of ecotropic viral integration site-1 (EVI1) overexpression on the prognosis of acute myeloid leukemia with KMT2A gene rearrangement in different risk stratification subtypes
Author: Liu, Xin-Xin; Pan, Xin-An; Gao, Meng-Ge; Kong, Jun; Jiang, Hao; Chang, Ying-Jun; Zhang, Xiao-Hui; Wang, Yu; Liu, Kai-Yan; Chen, Zhong; Zhao, Xiao-Su; Huang, Xiao-Jun

Journal: INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY. 2023; Vol. 45, Issue 2, pp. 195-203. DOI: 10.1111/ijlh.13987
8、Interleukin-10 promoter variability is associated with the susceptibility, severity, and clinical outcomes of aplasitc anemia in Han-Chinese population
Author: Wang, Shichong; You, Yahong; Ge, Meili; Shao, Yingqi; Huo, Jiali; Ren, Xiang; Li, Xingxin; Huang, Jinbo; Zhang, Jing; Wang, Min; Nie, Neng; Jin, Peng; Zheng, Yizhou

Journal: INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY. 2023; Vol. 45, Issue 2, pp. 204-212. DOI: 10.1111/ijlh.13993